James S McDonnell Foundation   Report issue

Foundation Phase 3
Founded: Saint Louis MO United States (1950)

Organization Overview

First Clinical Trial
2013
NCT01911195
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

James S McDonnell Foundation

Active Ingredients

Drugs in Phase 3 Trials (1)

cycloserine (seromycin) (1 trial)

Drugs in Other Trials (2)

isoflurane (forane) (1 trial)

ketamine (ketalar) (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3